Pilot randomised controlled trial of culturally adapted cognitive behavior therapy for psychosis (CaCBTp) in Pakistan

Muhammed Omair Husain, Imran B Chaudhry, Nasir Mehmood, Raza Ur Rehman, Ajmal Kazmi, Munir Hamirani, Tayyeba Kiran, Ameer Bukhsh, Paul Bassett, Muhammad Ishrat Husain, Farooq Naeem, Nusrat Husain, Muhammed Omair Husain, Imran B Chaudhry, Nasir Mehmood, Raza Ur Rehman, Ajmal Kazmi, Munir Hamirani, Tayyeba Kiran, Ameer Bukhsh, Paul Bassett, Muhammad Ishrat Husain, Farooq Naeem, Nusrat Husain

Abstract

Background: Evidence for efficacy of cognitive-behavioural therapy (CBT) in treatment of schizophrenia is growing. CBT is effective and cost efficient in treating positive and negative symptoms. To effectively meet the needs of diverse cultural groups, CBT needs to be adapted to the linguistic, cultural and socioeconomic context. We aimed to assess the feasibility, efficacy and acceptability of a culturally adapted CBT for treatment of psychosis (CaCBTp) in a low-income country.

Methods: Rater-blind, randomised, controlled trial of the use of standard duration CBT in patients with psychosis from a low-income country. Participants with a ICD-10 diagnosis of psychosis were assessed using Positive and Negative Syndrome Scale for Schizophrenia (PANSS), Psychotic Symptom Rating Scales (PSYRATS), and the Schedule for Assessment of Insight (SAI) (baseline, 3 months and 6 months). They were randomized into the intervention group (n = 18) and Treatment As Usual (TAU) group (n = 18). The intervention group received 12 weekly sessions of CaCBTp.

Results: The CaCBTp group had significantly lower scores on PANSS Positive (p = 0.02), PANSS Negative (p = 0.045), PANSS General Psychopathology (p = 0.008) and Total PANSS (p = 0.05) when compared to TAU at three months. They also had low scores on Delusion Severity Total (p = 0.02) and Hallucination Severity Total (p = 0.04) of PSYRATS, as well as higher scores on SAI (p = 0.01) at the same time point. At six months only the improvement in PANSS positive scores (p = 0.045) met statistical significance..

Conclusions: It is feasible to offer CaCBTp as an adjunct to TAU in patients with psychosis, presenting to services in a lower middle-income country.

Trial registration: Clinicaltrials.gov identifier NCT02202694 (Retrospectively registered).

Keywords: Cognitive behavioural therapy; Culture; Pakistan; Psychosis; Schizophrenia.

Conflict of interest statement

Ethics approval and consent to participate

Ethical approval was sought from DUHS (Dow University of Health Sciences, Karachi) research Ethics Committee (Reference: IRB-239/DUHS-11). Confidentiality was protected by anonymising data. No participant was identified in any analysis. If any participant showed signs of deterioration linked to session work, increased monitoring was arranged through their mental health team. Data was collected in a non-coercive manner. All participants provided written informed consent.

The research team consisted of registered/accredited mental health practitioners. Data Protection considerations were fully complied with. Any participant who wished to withdraw for any reason from the project had the right to do so at any time with no negative impact on their ongoing management.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Consort flow chart

References

    1. World Health Organization. The global burden of disease: 2004. Update. 2008; . Accessed 06 June 2016
    1. Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review of meta-analysis. Lancet. 2012;379(9831):2063–2071. doi: 10.1016/S0140-6736(12)60239-6.
    1. Garety PA, Fowler D, Kuipers E. Cognitive-behavioural therapy for medication-resistant symptoms. Schizophr Bull. 2000;26(1):73–86. doi: 10.1093/oxfordjournals.schbul.a033447.
    1. Grech E. A review of the current evidence for the use of psychological interventions in psychosis. Int J Psychosoc Rehabil. 2002;6:79–88.
    1. Haddock G, Barrowclough C, Shaw JJ, Dunn G, Novaco RW, Tarrier N. Cognitive-behavioural therapy v. Social activity therapy for people with psychosis and a history of violence: randomised controlled trial. Br J Psychiatry. 2009; doi:10.1192/bjp.bp.107.039859.
    1. Lincoln TM, Ziegler M, Mehl S, Kesting ML, Lullmann E, Westermann S, et al. Moving from efficacy to effectiveness in cognitive behavioural therapy for psychosis: a randomized clinical practice trial. J Consult Clin Psychol. 2012; doi:10.1037/a0028665.
    1. Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014; doi:10.1192/bjp.bp.112.116285.
    1. Pontillo M, De Crescenzo F, Vicari S, Pucciarini ML, Averna R, Santonastaso O, et al. Cognitive behavioural therapy for auditory hallucinations in schizophrenia: a review. World J Psychiatry. 2016; doi:10.5498/wjp.v6.i3.372.
    1. Turkington D, Kingdon D, Rathod S, Hammond K, Pelton J, Mehta R. Outcomes of an effectiveness trial of cognitive-behavioural intervention by mental health nurses in schizophrenia. Br J Psychiatry. 2006;189:36–40. doi: 10.1192/bjp.bp.105.010884.
    1. National Institute for Clinical Excellence. Psychosis and schizophrenia in adults: treatment and management. London: National Institute for Clinical Excellence. 2014.
    1. Araya R, Rojas G, Fritsch R, Gaete J, Rojas M, Simon G, et al. Treating depression in primary care in low-income women in Santiago, Chile: a randomized controlled trial. Lancet. 2003;361:995–1000. doi: 10.1016/S0140-6736(03)12825-5.
    1. Naeem F, Waheed W, Gobbi M, Ayub M, Kingdon D. Preliminary evaluation of culturally sensitive CBT for depression in Pakistan: findings from developing culturally-sensitive CBT project (DCCP) Behav Cogn Psychother. 2011;39:165–173. doi: 10.1017/S1352465810000822.
    1. Husain N, Afsar S, Ara J, Fayyaz H, ur Rahman R, Tomenson B, et al. Brief psychological intervention after self-harm: randomised controlled trial from Pakistan. Br J Psychiatry. 2014; 10.1192/bjp.bp.113.138370.
    1. Beck A, Nadkarni A, Calam R, Naeem F, Husain N. Increasing access to cognitive behaviour therapy in low and middle income countries: a strategic framework. Asian J Psychiatr. 2015; doi:10.1016/j.ajp.2015.10.008.
    1. Naeem F, Ayub M, Gobbi M, Kingdon D. Development of Southampton adaptation framework for CBT (SAF-CBT): a framework for adaptation of CBT in non-western culture. J Pakistan psychiatric Soc. 2009; doi:10.12669/pjms.314.7385.
    1. Griner D, Smith TB. Culturally adapted mental health intervention: a meta-analytic review. Psychotherapy (Chic). 2006; doi:10.1037/0033-3204.43.4.531.
    1. Degnan A, Baker S, Edge D, Nottidge W, Noke M, Press CJ, et al. The nature and efficacy of culturally-adapted psychosocial interventions for schizophrenia: a systematic review and meta-analysis. Psychol Med. 2017; doi:10.1017/S0033291717002264.
    1. Rathod S, Phiri P, Harris S, Underwood C, Thagadur M, Padmanabi U, et al. Cognitive behaviour therapy for psychosis can be adapted for minority ethnic groups: a randomised controlled trial. Schizophr Res. 2013; doi:10.1016/j.schres.2012.11.007.
    1. Naeem F, Saeed S, Irfan M, Kiran T, Mehmood N, Gul M et al. Brief culturally adapted CBT for psychosis (CaCBTp): A randomized controlled trial from a low income country. Schizophr Res. 2015; doi:10.1016/j.schres.2015.02.015.
    1. Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005; 4:287–291.
    1. Sim J, Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol. 2012; 65:301-308.
    1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–76.
    1. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol Med. 1999;29(4):879–89.
    1. David A, Buchanan A, Reed A, Almeida O.. The assessment of insight in psychosis. British Journal of Psychiatry. 1992;161: 599–602.
    1. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3(4):247–51.
    1. Ahmer S, Faruqui RA, Aijaz A. Psychiatric rating scales in Urdu: a systematic review. BMC Psychiatry. 2007; doi:10.1186/1471-244X-7-59
    1. Kingdon D, Turkington D. Cognitive-Behavioural Therapy of Schizophrenia. Hove: Lawrence Erlbaum; 1994.
    1. Gater R, Waheed W, Husain N, Tomenson B, Aseem S, Creed F. Social intervention for British Pakistani women with depression: randomised controlled trial. Br J Psychiatry. 2010; doi:10.1192/bjp.bp.109.066845.
    1. Chowdhary N, Jotheeswaran AT, Nadkarnim A, Hollon SD, King M, Jordans MJ et al. The methods and outcomes of cultural adaptations of psychological treatments for depressive disorders: a systematic review. Psychol Med. 2014; doi:10.1017/S0033291713001785
    1. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behaviour therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34:523–537. doi: 10.1093/schbul/sbm114.
    1. Rahman A, Malik A, Sikander S, Roberts C, Creed F. Cognitive behaviour therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomised controlled trial. Lancet. 2008;372(9642):902–9.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner